Search

Search Results for "PULSAR"

A Closer Look at 8 mg Aflibercept thumbnail

A Closer Look at 8 mg Aflibercept

David R. Chow, MD, FRCS(C)

96-Week Safety Data Revealed for 8 mg Aflibercept thumbnail

96-Week Safety Data Revealed for 8 mg Aflibercept

Christina Y. Weng, MD, MBA

Phase 3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of Wet
AMD thumbnail

Phase 3 Clinical Trial Data for EYLEA HD^® (aflibercept) Injection 8 mg for the Treatment of Wet AMD

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

New Retina Radio AAO Late-Breakers: PULSAR at 96 Weeks and Home OCT in Wet AMD

Jean-François Korobelnik, MD, PhD; and W. Lloyd Clark, MD

ARVO 2024 Coverage: ≥20-week Dosing in PULSAR and TENAYA/LUCERNE

Philip Storey, MD; and Prof. Sobha Sivaprasad

View More